Xilio Therapeutics
XLO
#9728
Rank
$34.83 M
Marketcap
$0.67
Share price
-1.00%
Change (1 day)
-54.22%
Change (1 year)

Revenue for Xilio Therapeutics (XLO)

Revenue in 2024 (TTM): $6.34 Million USD

According to Xilio Therapeutics's latest financial reports the company's current revenue (TTM ) is $6.34 Million USD. .The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xilio Therapeutics from 2021 to 2024

Annual revenue

Year Revenue Change
2024 $6.34 M
2022 N/A
2021 N/A